Modification of human serum albumin by acrylamide at cysteine-34: A basis for a rapid biomonitoring procedure (Letter to the editor)

Noort, D.; Fidder, A.; Hulst, A.G.

Modification of human serum albumin by acrylamide at cysteine-34: A basis for a rapid biomonitoring procedure (Letter to the editor)

article

2003

Noort, D.

Fidder, A.

Hulst, A.G.

Topics

Cysteine 34 Unclassified drug Amino terminal sequence Bioavailability Biological monitoring Blood sampling Carcinogenicity Diet Exposure Humans Instrumentation Protein isolation Protein modification Protein processing Reaction analysis Sequence analysis Spectrometry Alkylation Serum albumin Spectrometry, Mass, Electrospray Ionization Acrylamide, 79-06-1 Cysteine, 4371-52-2, 52-89-1, 52-90-4 Human serum albumin, 9048-49-1 Acrylamides Biological markers

TNO Identifier

237247

Repository link

https://resolver.tno.nl/uuid:11e26034-3701-4185-b10a-51424f10d0a4

ISSN

0340-5761

Source

Archives of Toxicology, 77(9), pp. 543-545.

Pages

543-545

Files

To receive the publication files, please send an e-mail request to TNO Repository.

Modification of human serum albumin by acrylamide at cysteine-34: A basis for a rapid biomonitoring procedure (Letter to the editor)

Make TNO yours!